These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

110 related articles for article (PubMed ID: 2543042)

  • 1. Why high levels of virus-specific CTL persist in HIV1-infected individuals.
    Koup RA; Sullivan JL
    Res Immunol; 1989 Jan; 140(1):92-5; discussion 118-9. PubMed ID: 2543042
    [No Abstract]   [Full Text] [Related]  

  • 2. Progressive loss of IL-2-expandable HIV-1-specific cytotoxic T lymphocytes during asymptomatic HIV infection.
    Jin X; Wills M; Sissons JG; Carmichael A
    Eur J Immunol; 1998 Nov; 28(11):3564-76. PubMed ID: 9842899
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Human immunodeficiency virus type 1 (HIV-1)--and Epstein-Barr virus--specific cytotoxic T lymphocyte precursors exhibit different kinetics in HIV-1--infected persons.
    Geretti AM; Dings ME; van Els CA; van Baalen CA; Wijnholds FJ; Borleffs JC; Osterhaus AD
    J Infect Dis; 1996 Jul; 174(1):34-45. PubMed ID: 8656011
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparative clonal analysis of human immunodeficiency virus type 1 (HIV-1)-specific CD4+ and CD8+ cytolytic T lymphocytes isolated from seronegative humans immunized with candidate HIV-1 vaccines.
    Hammond SA; Bollinger RC; Stanhope PE; Quinn TC; Schwartz D; Clements ML; Siliciano RF
    J Exp Med; 1992 Dec; 176(6):1531-42. PubMed ID: 1460417
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Quantitative analysis of the human immunodeficiency virus type 1 (HIV-1)-specific cytotoxic T lymphocyte (CTL) response at different stages of HIV-1 infection: differential CTL responses to HIV-1 and Epstein-Barr virus in late disease.
    Carmichael A; Jin X; Sissons P; Borysiewicz L
    J Exp Med; 1993 Feb; 177(2):249-56. PubMed ID: 8093890
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Influenza and its vaccination in HIV1-AIDS patients.
    Mathé G
    Biomed Pharmacother; 2000 May; 54(4):175-7. PubMed ID: 10872715
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Multiple cytotoxic effector cells are induced by infection with the human immunodeficiency virus.
    Rivière Y; Tanneau-Salvadori F; Regnault A; Lopez O; Sansonetti P; Guy B; Kieny MP; Fournel JJ; Montagnier L
    Res Immunol; 1989 Jan; 140(1):110-5; discussion 121. PubMed ID: 2657908
    [No Abstract]   [Full Text] [Related]  

  • 8. Autologous strain-specific cytolytic T lymphocyte responses directed against human immunodeficiency virus type 1 Env.
    Ray SC; Lubaki N; Dhruva BR; Siliciano RF; Bollinger RC
    AIDS Res Hum Retroviruses; 1998 Jan; 14(1):3-13. PubMed ID: 9453246
    [TBL] [Abstract][Full Text] [Related]  

  • 9. High frequency of Gag- and envelope-specific cytotoxic T lymphocyte precursors in children with vertically acquired human immunodeficiency virus type 1 infection.
    McFarland EJ; Harding PA; Luckey D; Conway B; Young RK; Kuritzkes DR
    J Infect Dis; 1994 Oct; 170(4):766-74. PubMed ID: 7930716
    [TBL] [Abstract][Full Text] [Related]  

  • 10. HIV-specific cytotoxic T lymphocytes in seropositive individuals.
    Walker BD; Chakrabarti S; Moss B; Paradis TJ; Flynn T; Durno AG; Blumberg RS; Kaplan JC; Hirsch MS; Schooley RT
    Nature; 1987 Jul 23-29; 328(6128):345-8. PubMed ID: 3496541
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Occurrence of human immunodeficiency virus type 1 (HIV-1)-specific cytolytic T cell activity in apparently uninfected children born to HIV-1-infected mothers.
    De Maria A; Cirillo C; Moretta L
    J Infect Dis; 1994 Nov; 170(5):1296-9. PubMed ID: 7963731
    [TBL] [Abstract][Full Text] [Related]  

  • 12. HIV-specific cytotoxic T-cells in HIV-exposed but uninfected Gambian women.
    Rowland-Jones S; Sutton J; Ariyoshi K; Dong T; Gotch F; McAdam S; Whitby D; Sabally S; Gallimore A; Corrah T
    Nat Med; 1995 Jan; 1(1):59-64. PubMed ID: 7584954
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cytotoxic T lymphocytes specific for the simian immunodeficiency virus.
    Letvin NL; Schmitz JE; Jordan HL; Seth A; Hirsch VM; Reimann KA; Kuroda MJ
    Immunol Rev; 1999 Aug; 170():127-34. PubMed ID: 10566147
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Eventual AIDS vaccine failure in a rhesus monkey by viral escape from cytotoxic T lymphocytes.
    Barouch DH; Kunstman J; Kuroda MJ; Schmitz JE; Santra S; Peyerl FW; Krivulka GR; Beaudry K; Lifton MA; Gorgone DA; Montefiori DC; Lewis MG; Wolinsky SM; Letvin NL
    Nature; 2002 Jan; 415(6869):335-9. PubMed ID: 11797012
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Antiviral pressure exerted by HIV-1-specific cytotoxic T lymphocytes (CTLs) during primary infection demonstrated by rapid selection of CTL escape virus.
    Borrow P; Lewicki H; Wei X; Horwitz MS; Peffer N; Meyers H; Nelson JA; Gairin JE; Hahn BH; Oldstone MB; Shaw GM
    Nat Med; 1997 Feb; 3(2):205-11. PubMed ID: 9018240
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Relationship between human immunodeficiency virus type 1 (HIV-1)-specific memory cytotoxic T lymphocytes and virus load after recent HIV-1 seroconversion.
    Connick E; Schlichtemeier RL; Purner MB; Schneider KM; Anderson DM; MaWhinney S; Campbell TB; Kuritzkes DR; Douglas JM; Judson FN; Schooley RT
    J Infect Dis; 2001 Dec; 184(11):1465-9. PubMed ID: 11709791
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cytotoxic T cells--protection from disease progression--protection from infection.
    Gotch F; Gallimore A; McMichael A
    Immunol Lett; 1996 Jun; 51(1-2):125-8. PubMed ID: 8811356
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Why can't cytotoxic T cells handle HIV?
    Bevan MJ; Braciale TJ
    Proc Natl Acad Sci U S A; 1995 Jun; 92(13):5765-7. PubMed ID: 7597026
    [No Abstract]   [Full Text] [Related]  

  • 19. Evidence of presentation of multiple HIV-1 cytotoxic T lymphocyte epitopes by HLA-B*3501 molecules that are associated with the accelerated progression of AIDS.
    Tomiyama H; Miwa K; Shiga H; Moore YI; Oka S; Iwamoto A; Kaneko Y; Takiguchi M
    J Immunol; 1997 May; 158(10):5026-34. PubMed ID: 9144523
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Loss of T-cell cytotoxic responses in the course of HIV-1 infection.
    Zerhouni B; Sanhadji K; Touraine JL
    Thymus; 1997; 24(4):203-19. PubMed ID: 9493284
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.